All In Biotech

Drug Trial Radar · NCT03989206

Long-term Safety and Efficacy of Nemolizumab With Moderate-to-severe Atopic Dermatitis

A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Moderate-to-Severe Atopic Dermatitis

Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,935

Actual

Start

Dec 30, 2019

Primary completion

Aug 31, 2026

Study completion Aug 31, 2026

Sponsor

Lead sponsor
Galderma R&DIndustry
Sponsor type
Industry
First posted
Jun 18, 2019

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Long-Term Safety and Efficacy of Nemolizumab in Subjects with Moderate-to-Severe Atopic Dermatitis Description

Conditions

  • Moderate-to-Severe Atopic Dermatitis

Interventions

  • NemolizumabDrug

    Nemolizumab

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence and Severity of TEAEsTime frame: Baseline to Week 200
  2. Incidence of Serious TEAEsTime frame: Baseline to Week 200
  3. Incidence and Severity of Adverse Events of Special Interest (AESIs) Throughout the StudyTime frame: Baseline to Week 200

Locations

343 sites in 22 countries. Site status is shown where the registry gives one.

  • Galderma Investigational Site 8749

    Birmingham, Alabama

  • Galderma Investigational Site 8893

    Birmingham, Alabama

  • Galderma Investigational Site 8866

    Guntersville, Alabama

  • Galderma Investigational Site 8808

    Scottsdale, Arizona

  • Galderma Investigational Site 8873

    Scottsdale, Arizona

  • Galderma Investigational Site 8447

    Fort Smith, Arkansas

  • Galderma Investigational Site 8880

    North Little Rock, Arkansas

  • Galderma Investigational Site 8831

    Anaheim, California

  • Galderma Investigational Site 8906

    Bell Gardens, California

  • Galderma Investigational Site 8456

    Beverly Hills, California

  • Galderma Investigational Site 8578

    Cerritos, California

  • Galderma Investigational Site 8577

    Encinitas, California

  • Galderma Investigational Site 8636

    Fountain Valley, California

  • Galderma Investigational Site 8224

    Fremont, California

  • Galderma Investigational Site 8791

    Fresno, California

  • Galderma Investigational Site 8888

    Fullerton, California

  • Galderma Investigational Site 8845

    Huntington Beach, California

  • Galderma Investigational Site 8833

    Inglewood, California

  • Galderma Investigational Site 8686

    Lomita, California

  • Galderma Investigational Site 8674

    Los Angeles, California

  • Galderma Investigational Site 8683

    Los Angeles, California

  • Galderma Investigational Site 8813

    Los Angeles, California

  • Galderma Investigational Site 8907

    Newport Beach, California

  • Galderma Investigational Site 8799

    Ontario, California

  • Galderma Investigational Site 8745

    Pasadena, California

  • Galderma Investigational Site 8671

    San Diego, California

  • Galderma Investigational Site 8692

    San Diego, California

  • Galderma Investigational Site 8658

    San Diego, California

  • Galderma Investigational Site 8125

    San Francisco, California

  • Galderma Investigational Site 8536

    Santa Ana, California

  • Galderma Investigational Site 8608

    Santa Monica, California

  • Galderma Investigational Site 8820

    Westminster, California

  • Galderma Investigational Site 8637

    Farmington, Connecticut

  • Galderma Investigational Site 8870

    Boca Raton, Florida

  • Galderma Investigational Site 8805

    Cape Coral, Florida

  • Galderma Investigational Site 8786

    Clearwater, Florida

  • Galderma Investigational Site 8902

    Doral, Florida

  • Galderma Investigational Site 8391

    Hialeah, Florida

  • Galderma Investigational Site 8804

    Hialeah, Florida

  • Galderma Investigational Site 8711

    Jacksonville, Florida

Showing 40 of 343 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.